Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 14.55
+0.15 (1.04%)
Jul 1, 2026, 10:45 AM CST
SHA:600521 Market Cap
SHA:600521 has a market cap or net worth of 21.46 billion as of June 30, 2026. Its market cap has decreased by -22.50% in one year.
Market Cap
21.46B
Enterprise Value
28.16B
Revenue
8.55B
Ranking
n/a
PE Ratio
57.89
Stock Price
14.55
Market Cap Chart
Since March 4, 2003, SHA:600521's market cap has increased from 3.97B to 21.46B, an increase of 440.43%. That is a compound annual growth rate of 7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 21.46B | -15.14% |
| Dec 31, 2025 | 25.29B | -2.34% |
| Dec 31, 2024 | 25.89B | 19.93% |
| Dec 29, 2023 | 21.59B | -33.42% |
| Dec 30, 2022 | 32.43B | 0.57% |
| Dec 31, 2021 | 32.25B | -34.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Betta Pharmaceuticals | 24.35B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.32B |
| Hubei Jumpcan Pharmaceutical | 23.41B |
| Livzon Pharmaceutical Group | 22.81B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 20.84B |
| Jilin Aodong Pharmaceutical Group | 20.56B |
| Walvax Biotechnology | 20.54B |
| Tasly Pharmaceutical Group | 20.44B |